These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18255024)

  • 1. Balancing between adaptive and maladaptive cellular stress responses in peripheral neuropathy.
    Khajavi M; Lupski JR
    Neuron; 2008 Feb; 57(3):329-30. PubMed ID: 18255024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral neuropathies caused by mutations in the myelin protein zero.
    Shy ME
    J Neurol Sci; 2006 Mar; 242(1-2):55-66. PubMed ID: 16414078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathogenesis of peripheral neuropathy.
    Trapp BD; Haney C; Yin X
    Rev Neurol (Paris); 1996 May; 152(5):314-9. PubMed ID: 8881422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuated demyelination in the absence of the macrophage-restricted adhesion molecule sialoadhesin (Siglec-1) in mice heterozygously deficient in P0.
    Kobsar I; Oetke C; Kroner A; Wessig C; Crocker P; Martini R
    Mol Cell Neurosci; 2006 Apr; 31(4):685-91. PubMed ID: 16458537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ablation of the UPR-mediator CHOP restores motor function and reduces demyelination in Charcot-Marie-Tooth 1B mice.
    Pennuto M; Tinelli E; Malaguti M; Del Carro U; D'Antonio M; Ron D; Quattrini A; Feltri ML; Wrabetz L
    Neuron; 2008 Feb; 57(3):393-405. PubMed ID: 18255032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The co-inhibitory molecule PD-1 modulates disease severity in a model for an inherited, demyelinating neuropathy.
    Kroner A; Schwab N; Ip CW; Sommer C; Wessig C; Wiendl H; Martini R
    Neurobiol Dis; 2009 Jan; 33(1):96-103. PubMed ID: 18996482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glomerular permeability is altered by loss of P0, a myelin protein expressed in glomerular epithelial cells.
    Plaisier E; Mougenot B; Verpont MC; Jouanneau C; Archelos JJ; Martini R; Kerjaschki D; Ronco P
    J Am Soc Nephrol; 2005 Nov; 16(11):3350-6. PubMed ID: 16162811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An active dominant mutation of glycyl-tRNA synthetase causes neuropathy in a Charcot-Marie-Tooth 2D mouse model.
    Seburn KL; Nangle LA; Cox GA; Schimmel P; Burgess RW
    Neuron; 2006 Sep; 51(6):715-26. PubMed ID: 16982418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effect of the immune system in a mouse model of severe dysmyelinating hereditary neuropathy: enhanced axonal degeneration following disruption of the RAG-1 gene.
    Berghoff M; Samsam M; Müller M; Kobsar I; Toyka KV; Kiefer R; Mäurer M; Martini R
    Mol Cell Neurosci; 2005 Jan; 28(1):118-27. PubMed ID: 15607947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hereditary neuropathies].
    Maisonobe T
    Rev Prat; 2000 Apr; 50(7):736-42. PubMed ID: 10853553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus (FK506) causes disease aggravation in models for inherited peripheral myelinopathies.
    Ip CW; Kroner A; Kohl B; Wessig C; Martini R
    Neurobiol Dis; 2009 Feb; 33(2):207-12. PubMed ID: 19028581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of immune cells in animal models for inherited peripheral neuropathies.
    Wang Ip C; Kroner A; Fischer S; Berghoff M; Kobsar I; Mäurer M; Martini R
    Neuromolecular Med; 2006; 8(1-2):175-90. PubMed ID: 16775375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal expression of myelin protein zero with frame-shift mutation correlates with mild phenotype.
    Steck AJ; Erne B; Pareyson D; Sghirlanzoni A; Taroni F; Schaeren-Wiemers N
    J Peripher Nerv Syst; 2006 Mar; 11(1):61-6. PubMed ID: 16519783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe demyelinating hypertrophic polyneuropathy caused by a de novo frameshift mutation within the intracellular domain of myelin protein zero (MPZ/P0).
    Zschüntzsch J; Dibaj P; Pilgram S; Kötting J; Gerding WM; Neusch C
    J Neurol Sci; 2009 Jun; 281(1-2):113-5. PubMed ID: 19344920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in the cytoplasmic domain of P0 reveal a role for PKC-mediated phosphorylation in adhesion and myelination.
    Xu W; Shy M; Kamholz J; Elferink L; Xu G; Lilien J; Balsamo J
    J Cell Biol; 2001 Oct; 155(3):439-46. PubMed ID: 11673479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inherited neuropathies: new genes don't fit old models.
    Scherer SS
    Neuron; 2006 Sep; 51(6):672-4. PubMed ID: 16982409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous antibodies contribute to macrophage-mediated demyelination in a mouse model for CMT1B.
    Klein D; Groh J; Weishaupt A; Martini R
    J Neuroinflammation; 2015 Mar; 12():49. PubMed ID: 25879857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depleting endogenous neurotrophin-3 enhances myelin formation in the Trembler-J mouse, a model of a peripheral neuropathy.
    Liu N; Varma S; Tsao D; Shooter EM; Tolwani RJ
    J Neurosci Res; 2007 Oct; 85(13):2863-9. PubMed ID: 17628499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune deficiency in mouse models for inherited peripheral neuropathies leads to improved myelin maintenance.
    Schmid CD; Stienekemeier M; Oehen S; Bootz F; Zielasek J; Gold R; Toyka KV; Schachner M; Martini R
    J Neurosci; 2000 Jan; 20(2):729-35. PubMed ID: 10632602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and molecular genetics of hereditary peripheral neuropathies.
    Kuhlenbäumer G; Young P; Hünermund G; Ringelstein B; Stögbauer F
    J Neurol; 2002 Dec; 249(12):1629-50. PubMed ID: 12529785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.